long term effects of glp 1 drugs GI Adverse Glucagon-Like Peptide-1 Receptor Agonists long term effects of glp

The study highlights that after stopping GLP-1 medications, many patients resume treatment or try alternatives, influencing weight management strategies.

The GLP-1 Receptor Agonist market size is expected to reach $18.32 billion in 2030 at a CAGR of 5.4%, driven by rising prevalence of diabetes.

Ozempic alternatives for weight loss span branded medications, compounded formulations, and lifestyle-based approaches

Explore changes in HbA1c and body weight over 26 weeks with DURATION-2.

bimagrumab) may improve the body composition during WL and are in early phase clinical trials

Coronary artery disease (CAD)cardiovascular condition occuring due to atherosclerotic plaque accumulation in the epicardial arteriesis responsible for disa...